Skip to contentSkip to Braille Studio

Library / Laws / 116th Congress / Senate Bills / S. 660

S. 660

To address abuse of the Food and Drug Administration's citizen petition process by brand drug manufacturers.

Print stageDateSize⠃
Introduced in Senate2019-03-052.2K⠃⠗⠋